loadpatents
Patent applications and USPTO patent grants for Bystryn; Jean-Claude.The latest application filed is for "cancer stem cell vaccine".
Patent | Date |
---|---|
Cancer Stem Cell Vaccine App 20100247623 - Bystryn; Jean-Claude | 2010-09-30 |
Topical Toll Like Receptor Ligands as Vaccine Adjuvants App 20090060928 - Bystryn; Jean-Claude | 2009-03-05 |
Anti-cancer vaccine Grant 7,402,317 - Bystryn July 22, 2 | 2008-07-22 |
Shed antigen vaccine with dendritic cells adjuvant App 20070259006 - Bystryn; Jean-Claude | 2007-11-08 |
Shed antigen vaccine with dendritic cells adjuvant App 20040022813 - Bystryn, Jean-Claude | 2004-02-05 |
Anti-cancer vaccine App 20020164358 - Bystryn, Jean-Claude | 2002-11-07 |
Anti-cancer vaccine Grant 6,338,853 - Bystryn January 15, 2 | 2002-01-15 |
Anti-cancer vaccine Grant 5,635,188 - Bystryn June 3, 1 | 1997-06-03 |
Method for preparing human meloma vaccine Grant 5,194,384 - Bystryn March 16, 1 | 1993-03-16 |
Shed melanoma antigen compositions Grant 5,030,621 - Bystryn July 9, 1 | 1991-07-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.